These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 29904573)

  • 1. Results of early warning indicators for HIV/AIDS in 42 outpatient clinics in 25 northern provinces of Vietnam.
    Le HT; Doan LTT; Pham DK; Ngoc Hoang Le Q; Phuc Do H; Nguyen HLT
    F1000Res; 2017; 6():517. PubMed ID: 29904573
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring prevention or emergence of HIV drug resistance: results of a population-based foundational survey of early warning indicators in mainland Tanzania.
    Juma JM; Tiberio JK; Abuya MI; Kilama BK; Somi GR; Sambu V; Banda R; Jullu BS; Ramadhani AA
    BMC Infect Dis; 2014 Apr; 14():196. PubMed ID: 24725750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.
    Do TN; Nguyen TM; Do MH; Masaya K; Dang TB; Pham TL; Yoshikawa K; Cao TT; Nguyen TT; Bui DD; Nguyen VK; Nguyen TL; Fujita M
    Clin Infect Dis; 2012 May; 54 Suppl 4():S306-12. PubMed ID: 22544193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.
    Asio J; Watera C; Namuwenge N; Kirungi W; Musinguzi J; Mugagga K; Busobozi R; Tusiime BJ; Lutalo T; Mbidde EK; Kaleebu P;
    PLoS One; 2020; 15(4):e0230451. PubMed ID: 32287264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
    St-Jean M; Harrigan PR; Sereda P; Montaner J; Lima VD
    HIV Med; 2017 May; 18(5):342-353. PubMed ID: 27704659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.
    Hong SY; Jonas A; Dumeni E; Badi A; Pereko D; Blom A; Muthiani VS; Shiningavamwe AN; Mukamba J; Andemichael G; Barbara R; Bennett DE; Jordan MR
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):27-31. PubMed ID: 20838224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV drug-resistance early-warning indicators and quality care in India: preliminary findings from a pilot study in Pune city.
    Ghate M; Kadam D; Gaikwad N; Shankar S; Gurav S; Rahane G; Tanwar S; Rewari B; Gangakhedkar R
    WHO South East Asia J Public Health; 2015; 4(2):123-129. PubMed ID: 28607310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV drug resistance early warning indicators in Namibia for public health action.
    Jonas A; Gweshe J; Siboleka M; Deklerk M; Gawanab M; Badi A; Sumbi V; Pereko D; Blom A; Mwinga S; Jordan MR; Jerger L; Lau K; Hong SY
    PLoS One; 2013; 8(6):e65653. PubMed ID: 23762406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early warning indicators for HIV drug resistance in Cameroon during the year 2010.
    Billong SC; Fokam J; Nkwescheu AS; Kembou E; Milenge P; Tsomo Z; Dion GN; Aghokeng AF; Mpoudi EN; Ndumbe PM; Colizzi V; Elat Nfetam JB
    PLoS One; 2012; 7(5):e36777. PubMed ID: 22615810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.
    Bennett DE; Jordan MR; Bertagnolio S; Hong SY; Ravasi G; McMahon JH; Saadani A; Kelley KF
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S280-9. PubMed ID: 22544188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya.
    Pilgrim NA; Okal J; Matheka J; Mukui I; Kalibala S
    BMC Pediatr; 2018 Jul; 18(1):243. PubMed ID: 30045700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early warning indicators of HIV drug resistance in the southern highlands region of Tanzania: Lessons from a cross-sectional surveillance study.
    Khamadi SA; Mavere C; Bahemana E; Lwilla A; Mizinduko M; Bwigane S; Peter A; Makando J; Peter B; Agaba P; Shah N; Julu B; Ganesan K; Coakley P; Lee EH
    PLOS Glob Public Health; 2023; 3(3):e0000929. PubMed ID: 36996096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
    Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
    Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.
    Dzangare J; Gonese E; Mugurungi O; Shamu T; Apollo T; Bennett DE; Kelley KF; Jordan MR; Chakanyuka C; Cham F; Banda RM
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S313-6. PubMed ID: 22544194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
    Mutenda N; Bukowski A; Nitschke AM; Nakanyala T; Hamunime N; Mekonen T; Tjituka F; Mazibuko G; Mwinga S; Mabirizi D; Sagwa E; Indongo R; Dean N; Jordan MR; Hong SY
    PLoS One; 2016; 11(12):e0166649. PubMed ID: 27906995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008-2010.
    Dube NM; Tint KS; Summers RS
    Clin Infect Dis; 2014 Jun; 58(11):1607-14. PubMed ID: 24585566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of implementing an integrated tool for improvement of treatment quality and early-warning indicators for HIV drug resistance: a pilot study of centres in India.
    Rewari BB; Seguy NS; Tanwar SS; Chan PL; Purohit V; Harvey P; Yu D; Rathore AS
    WHO South East Asia J Public Health; 2015; 4(2):184-188. PubMed ID: 28607317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling.
    Billong SC; Fokam J; Penda CI; Amadou S; Kob DS; Billong EJ; Colizzi V; Ndjolo A; Bisseck AZ; Elat JN
    BMC Infect Dis; 2016 Nov; 16(1):678. PubMed ID: 27846809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural barriers for retention of HIV/AIDS patients after initiating antiretroviral therapy in outpatient clinics of Vietnam.
    Hoang NT; Foo TJ; Tran BX; Do NT; Vu GT; Nguyen CT; Pham HQ; Latkin CA; Ho CSH; Ho RCM
    AIDS Care; 2022 Aug; 34(8):992-999. PubMed ID: 34018428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.